Commercial Wearables for the Management of People with Autism Spectrum Disorder: A Review
Biosensors · 15.11.2024 · 14 (11) · 556
DOI: 10.3390/bios14110556 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 15.11.2024. Verfasst von Jonathan Hernández-Capistrán und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico. Hauptthemen laut MEDLINE: Wearable Electronic Devices, Autism Spectrum Disorder. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conahcyt, Mexico’s National Council of Science and Technology (CONACYT), Mexico’s National Technological Institute (TecNM).
Abstract (Originalsprache)
Autism Spectrum Disorder (ASD) necessitates comprehensive management, addressing complex challenges in social communication, behavioral regulation, and sensory processing, for which wearable technologies offer valuable tools to monitor and support interventions. Therefore, this review explores recent advancements in wearable technology, categorizing devices based on executive function, psychomotor skills, and the behavioral/emotional/sensory domain, highlighting their potential to improve ongoing management and intervention. To ensure rigor and comprehensiveness, the review employs a PRISMA-based methodology. Specifically, literature searches were conducted across diverse databases, focusing on studies published between 2014 and 2024, to identify the most commonly used wearables in ASD research. Notably, 55.45% of the 110 devices analyzed had an undefined FDA status, 23.6% received 510(k) clearance, and only a small percentage were classified as FDA Breakthrough Devices or in the submission process. Additionally, approximately 50% of the devices utilized sensors like ECG, EEG, PPG, and EMG, highlighting their widespread use in real-time physiological monitoring. Our work comprehensively analyzes a wide array of wearable technologies, including emerging and advanced. While these technologies have the potential to transform ASD management through real-time data collection and personalized interventions, improved clinical validation and user-centered design are essential for maximizing their effectiveness and user acceptance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.
- CONAHCYT-Tecnológico Nacional de México/I.T. Orizaba, Av. Oriente 9, 852. Col. Emiliano Zapata, Orizaba C.P. 94320, Veracruz, Mexico.
ORCID-Profile: Giner Alor-Hernández, Jose Luis Sanchez-Cervantes
Förderung
- Conahcyt
- Mexico’s National Council of Science and Technology (CONACYT)
- Mexico’s National Technological Institute (TecNM)
Zitieren
APA
Hernández-Capistrán, J., Alor-Hernández, G., Marín-Vega, H., Bustos-López, M., Sanchez-Morales, L. N., & Sanchez-Cervantes, J. L. (2024). Commercial Wearables for the Management of People with Autism Spectrum Disorder: A Review. Biosensors, 14(11), 556. https://doi.org/10.3390/bios14110556
Vancouver
Hernández-Capistrán J, Alor-Hernández G, Marín-Vega H, Bustos-López M, Sanchez-Morales LN, Sanchez-Cervantes JL. Commercial Wearables for the Management of People with Autism Spectrum Disorder: A Review. Biosensors. 2024;14(11):556. doi:10.3390/bios14110556
BibTeX
@article{HernndezCapistrn2024,
author = {Hernández-Capistrán, Jonathan and Alor-Hernández, Giner and Marín-Vega, Humberto and Bustos-López, Maritza and Sanchez-Morales, Laura Nely and Sanchez-Cervantes, Jose Luis},
title = {Commercial Wearables for the Management of People with Autism Spectrum Disorder: A Review},
journal = {Biosensors},
year = {2024},
volume = {14},
number = {11},
pages = {556},
doi = {10.3390/bios14110556}
}
EUVIMED